Quick Takeaways
- Deep Track Capital, LP filed SCHEDULE 13G for RAPT Therapeutics, Inc. Common Stock $0.0001 par value per share (RAPT).
- Disclosed ownership: 9.9%.
- Date of event: 23 Dec 2024.
Deep Track Capital, LP - 23 Dec 2024 SCHEDULE 13G Report for RAPT Therapeutics, Inc. Common Stock $0.0001 par value per share (RAPT)
- Filing Manager
- Deep Track Capital, LP
- Reporting Manager
- Deep Track Capital, LP
- Symbol
- RAPT
- Shares outstanding
- 143,019,250 shares
- Disclosed Ownership
- 14,116,000 shares
- Ownership
- 9.9%
- Form type
- SCHEDULE 13G
- Filing time
- 23 Dec 2024, 16:42:07 UTC
- Date of event
- 23 Dec 2024
- SEC
- View on sec.gov
Quoteable Key Fact
"Deep Track Capital, LP disclosed 9.9% ownership in RAPT Therapeutics, Inc. Common Stock $0.0001 par value per share (RAPT) on 23 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 23 Dec 2024, 16:42.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Deep Track Capital, LP | 9.9% | 14,116,000 | 0 | 14,116,000 | /s/ David Kroin | David Kroin, Managing Member of the General Partner of the Investment Adviser | |
| Deep Track Biotechnology Master Fund, Ltd. | 9.9% | 14,116,000 | 0 | 14,116,000 | /s/ David Kroin | David Kroin, Director | |
| David Kroin | 9.9% | 14,116,000 | 0 | 14,116,000 | /s/ David Kroin | David Kroin |